Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds

Details for Australian Patent Application No. 2004244755 (hide)

Owner Medical Enzymes AG

Inventors Seifert, Wenke; Leenders, Frank

Agent Davies Collison Cave

Pub. Number AU-B-2004244755

PCT Pub. Number WO2004/108153

Priority 103 26 821.9 11.06.03 DE

Filing date 11 June 2004

Wipo publication date 16 December 2004

Acceptance publication date 25 June 2009

International Classifications

A61K 31/704 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 38/50 (2006.01) Medicinal preparations containing peptides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/108153 Priority application(s): WO2004/108153

25 June 2009 Application Accepted

  Published as AU-B-2004244755

22 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004244756-Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects

2004244750-Method and device for extracting milk from animals